Drug Approval | June 13, 2026
UK approves Wegovy pill in major shift in obesity treatment options
Approval is based on results from the phase 3 OASIS 4 clinical trial
Approval is based on results from the phase 3 OASIS 4 clinical trial
Dr. Quirk said the program’s mechanism offers a targeted approach to disrupted brain signaling in compulsivity-related disorders
KIHT can now conduct clinical research for drugs and medical devices, strengthening evidence generation and healthcare innovation
Company may qualify for 180-day generic exclusivity as sole first applicant for Bayer’s Vitrakvi capsules in the U.S.
Enhanced CMC infrastructure at Cranbury site aims to improve bioavailability, streamline formulation development and support faster progression of challenging drug candidates into clinical trials
Collaboration aims to accelerate medicinal chemistry decision-making, reduce synthesis burden and strengthen data-secure AI adoption in drug discovery
Preclinical CRO strengthens leadership team with key executive appointments as it scales its human tissue-based drug discovery platform
7.5 crore antenatal check-ups and 1.2 crore high-risk pregnancies identified under flagship programme as maternal and neonatal mortality declines
The fast growing pharma industry in India offers us a wide range of opportunities and we represent the world's leading technology providers in india
Tomoyuki Hasegawa has been appointed CEO of FUJIFILM Biotechnologies California
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
